This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Alzheimer's Institute of America, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations in Cancer Treatment by Jeffrey S. Flick
Introduction
Jeffrey S. Flick is an accomplished inventor based in Salt Lake City, UT. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on therapeutic and diagnostic approaches that target specific cancer pathways.
Latest Patents
Jeffrey S. Flick holds a patent for therapeutic and diagnostic methods related to the treatment of diseases, particularly cancers. This invention involves methods that inhibit Nicotinamide phosphoribosyltransferase (Nampt), which is crucial for cancer cell survival. The patent outlines therapeutic methods that utilize Nampt inhibitors in combination with NAD biosynthesis precursors. This combination aims to intentionally kill cancer cells while minimizing toxicity to normal host cells. Additionally, the patent includes methods for identifying cancers that are most responsive to treatment with Nampt inhibitors, especially when administered alongside nicotinic acid.
Career Highlights
Jeffrey S. Flick is associated with the Alzheimer's Institute of America, Inc., where he continues to advance his research in therapeutic methods. His work has the potential to change the landscape of cancer treatment, providing new avenues for effective therapies.
Collaborations
He has collaborated with notable colleagues, including Vijay R. Baichwal and Daniel M. Cimbora, to further enhance the impact of his research and innovations.
Conclusion
Jeffrey S. Flick's contributions to cancer treatment through his patented methods demonstrate his commitment to advancing medical science. His innovative approaches hold promise for improving patient outcomes in the fight against cancer.